Anaphylaxis in a Swiss university emergency department: clinical characteristics and supposed triggers
- PMID: 38822425
- PMCID: PMC11140950
- DOI: 10.1186/s13223-024-00901-y
Anaphylaxis in a Swiss university emergency department: clinical characteristics and supposed triggers
Abstract
Background: Anaphylaxis is the most severe form of acute systemic and potentially life-threatening reactions triggered by mast and basophilic cells. Recent studies show a worldwide incidence between 50 and 112 occurrences per 100,000 person-years. The most identified triggers are food, medications, and insect venoms. We aimed to analyze triggers and clinical symptoms of patients presenting to a Swiss university emergency department for adults.
Methods: Six-year retrospective analysis (01/2013 to 12/2018) of all patients (> 16 years of age) admitted with moderate or severe anaphylaxis (classification of Ring and Messmer ≥ 2) to the emergency department. Patient and clinical data were extracted from the electronic medical database of the emergency department.
Results: Of the 531 includes patients, 53.3% were female, the median age was 38 [IQR 26-51] years. The most common suspected triggers were medications (31.8%), food (25.6%), and insect stings (17.1%). Organ manifestations varied among the different suspected triggers: for medications, 90.5% of the patients had skin symptoms, followed by respiratory (62.7%), cardiovascular (44.4%) and gastrointestinal symptoms (33.7%); for food, gastrointestinal symptoms (39.7%) were more frequent than cardiovascular symptoms (36.8%) and for insect stings cardiovascular symptoms were apparent in 63.8% of the cases.
Conclusions: Average annual incidence of moderate to severe anaphylaxis during the 6-year period in subjects > 16 years of age was 10.67 per 100,000 inhabitants. Medications (antibiotics, NSAID and radiocontrast agents) were the most frequently suspected triggers. Anaphylaxis due to insect stings was more frequently than in other studies. Regarding clinical symptoms, gastrointestinal symptoms need to be better considered, especially that initial treatment with epinephrine is not delayed.
Keywords: Allergic reaction; Anaphylaxis; Emergency medicine; Symptoms; Triggers.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Use of epinephrine in anaphylaxis: a retrospective cohort study at a Swiss university emergency department.Swiss Med Wkly. 2023 Mar 22;153:40065. doi: 10.57187/smw.2023.40065. Swiss Med Wkly. 2023. PMID: 36971665
-
Clinical Manifestations and Causes of Anaphylaxis. Analysis of 382 Cases from the Anaphylaxis Registry in West Pomerania Province in Poland.Int J Environ Res Public Health. 2020 Apr 17;17(8):2787. doi: 10.3390/ijerph17082787. Int J Environ Res Public Health. 2020. PMID: 32316622 Free PMC article.
-
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).Allergol Select. 2023 Oct 2;7:154-190. doi: 10.5414/ALX02430E. eCollection 2023. Allergol Select. 2023. PMID: 37854067 Free PMC article.
-
Anaphylaxis: Recognition and Management.Am Fam Physician. 2020 Sep 15;102(6):355-362. Am Fam Physician. 2020. PMID: 32931210 Review.
-
Mastocytosis and Anaphylaxis.Immunol Allergy Clin North Am. 2017 Feb;37(1):153-164. doi: 10.1016/j.iac.2016.08.017. Epub 2016 Oct 28. Immunol Allergy Clin North Am. 2017. PMID: 27886904 Review.
Cited by
-
Characteristics and Outcomes of Anaphylaxis in Emergency Department Visits Among Older Adults.J Allergy Clin Immunol Pract. 2025 Aug;13(8):2014-2024.e4. doi: 10.1016/j.jaip.2025.04.023. Epub 2025 Apr 22. J Allergy Clin Immunol Pract. 2025. PMID: 40274230
References
-
- Ring J, Beyer K, Biedermann T, Bircher A, Fischer M, Fuchs T, et al. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE) Allergo J Int. 2021;30(1):1–25. doi: 10.1007/s40629-020-00158-y. - DOI - PMC - PubMed